Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1519 of 5804
-
New shot may curb heavy drinking in reward-driven people
Disease control Recruiting nowThis study is a phase IV, two-arm, randomized, double-blind, placebo-controlled study to assess whether individuals identified as primarily reward drinkers are significantly more likely to reduce heavy drinking if they receive XR-NTX than a matching placebo injection. Study subj…
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Do Heart-Strengthening drugs actually help in shock? major trial aims to find out
Disease control Recruiting nowThe investigators are interested in determining if there is a meaningful benefit from the use of medications purported to increase the pumping function of the heart (i.e. inotropes) among critically ill patients admitted to the Cardiac Intensive Care Unit (CICU). To do this, the …
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can a migraine pill taken daily or every other day stop attacks before they start?
Disease control CompletedThe purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.
Phase: PHASE4 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Seizure drug safety trial halted early for dravet and LGS patients
Disease control TerminatedThe main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in children and adults with Dravet Syndrome (DS) or Lennox-Gastaut Syndrome (LGS). Participants will receive their standard anti-seizure therapy, plus tablets of…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Miracle fruit tested as taste saver for head and neck cancer patients
Symptom relief OngoingPatients diagnosed with head and neck cancer who receive radiation therapy with and without chemotherapy develop altered sense of taste due to treatment effect, which typically arises in the second week of radiation therapy and progresses throughout the course of treatment. While…
Phase: PHASE3 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a cancer drug slow bile duct tumors?
Disease control Recruiting nowBackground: Cholangiocarcinoma (CCA) is an aggressive cancer of the bile ducts. People with CCA have few treatment options and poor survival. Researchers want to see if a new drug can stop or slow CCA growth. Objective: To find the safest and most effective dose of tivozanib t…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Heart shield for chemo: new trial aims to protect AML patients
Disease control Recruiting nowPatients with acute myeloid leukemia (AML) often receive a drug called daunorubicin. Daunorubicin is a type of drug called an anthracycline, which increases the risk of some damage to the heart. Beta blockers and angiotensin-converting enzyme inhibitors (ACEi) are two types of dr…
Phase: PHASE2 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Spit test could spot oral cancer before it spreads
Diagnosis Recruiting nowHead and neck squamous cell carcinoma (HNSCC) are malignant tumors originating from the epithelial mucosa of the upper aerodigestive tract. The oral cavity is the most frequent location of HNSCC (oral squamous cell carcinoma: OSCC). Tobacco use and alcohol consumption are the gre…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New drug could help people with short bowel syndrome ditch IV nutrition
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, proof-of-concept (PoC), Phase 2 study to assess the safety, PK, and PD of SC administration of HM15912(sonefpeglutide) in adult subjects with SBS-associated intestinal failure (SBS-IF).
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
5-Drug cocktail takes on tough cancers in new trial
Disease control Recruiting nowThe purpose of this Phase I/II study is to determine the safety and effectiveness of up to 5 study drugs used together for the treatment of solid tumor cancers. The drugs are hydroxychloroquine, metformin, sirolimus, dasatinib and nelfinavir and are given orally.
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Spinal zap hope: electrical stimulation may help kids with spinal injury walk
Symptom relief Recruiting nowAim 1: Determine the safety and feasibility of administration of TSCS to children in a clinical setting. Participants will be randomly assigned to experimental (TSCS) or control (sham stimulation) groups. Both groups will receive eight-weeks of individualized gait training. We wi…
Phase: NA • Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New device aims to fix leaky heart valve without open surgery
Disease control Recruiting nowThe objective of this early feasibility study is to gain early clinical insight into Trisol system safety and performance to treat patients with moderate or greater tricuspid regurgitation (TR).
Phase: NA • Sponsor: Trisol Medical • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smart shoes aim to stop diabetic foot ulcers in their tracks
Disease control CompletedPreventing foot ulcers in people with diabetes can reduce costs and increase quality of life. Despite availability of various interventions to prevent foot ulcers, recurrence rates remain high. We hypothesise that a multimodal approach incorporating a variety of orthotic interven…
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart surgery anesthesia showdown: can ketamine shield kidneys better than propofol?
Disease control OngoingThe purpose of this study is to investigate the affects of ketamine use for anesthesia at the beginning of heart surgery on kidneys compared to the use of propofol.
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo aims to outsmart resistant cancers
Disease control OngoingThis is a multi-centre Phase I dose finding and proof-of-concept study of the combination of ASTX660 together with Pembrolizumab with expansion cohorts testing preliminary efficacy in immune-refractory cancers, triple negative breast cancer (TNBC), cervical cancer, and glioblasto…
Phase: PHASE1 • Sponsor: Institute of Cancer Research, United Kingdom • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope: preventing diabetes in childhood cancer survivors
Prevention OngoingThis is a first-in survivor, single-arm pilot study with the goal of establishing evidence of feasibility and safety of a combined pharmacologic (metformin) and lifestyle intervention (using an existing digital platform) to prevent diabetes in prediabetic adult survivors of child…
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC
-
Could a simple blood test guide MS treatment? new study tests ofatumumab switch
Disease control OngoingThis study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) l…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New Drug-Free program shows promise for easing anxiety in severe mental illness
Symptom relief CompletedFew alternatives to addictive medical treatment exists for persons with severe mental health problems (SMHP) and anxiety, often connected to high risk of suicide. Access to effective interventions that depart in individuals' needs to cope with anxiety in everyday life is crucial …
Phase: NA • Sponsor: Lund University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Spinal zaps and exercise may boost walking after injury
Symptom relief OngoingFor many people with spinal cord injury (SCI), the goal of walking is a high priority. There are many approaches available to restore walking function after SCI; however, these approaches often involve extensive rehabilitation training and access to facilities, qualified staff, a…
Phase: NA • Sponsor: Shepherd Center, Atlanta GA • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Brain training targets voices in schizophrenia
Symptom relief Recruiting nowNeurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
Phase: NA • Sponsor: Boston VA Research Institute, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 18:46 UTC